In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Indian astronaut Shubhanshu Shukla is currently taking part in a historic mission on the International Space Station (ISS) as part of Axiom Mission 4 (Ax-4). He is involved in more than 60 scientific ...

Affiliate Content. Uncover what AI detection is already doing in your life—from tracking patterns in your online behavior to ...

Julian Melchiorri is an entrepreneur and innovator recognised for his pioneering work on photosynthesis and biomimicry. He is ...

Type 1 diabetes affects over 8 million people around the world. It’s a lifelong condition that occurs when the immune system ...

Technology is making patient care more personal and easier to get, like through virtual visits. Artificial intelligence (AI) ...

Continuous glucose monitoring reveals frequent dysglycaemia in very low birth weight infants nearing term age, with male sex ...

For patients with T2D, disparities in CGM prescriptions are seen by language preference, with less access for adult patients with non-English language preferences.

Pain avoidance as a key motivator: Numerous surveys in 2025 indicate that a major reason people avoid consistent health ...

Think you’re eating healthy but still gaining weight? Learn how common diet mistakes might be spiking insulin and blocking ...

GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...